<DOC>
	<DOCNO>NCT02712554</DOCNO>
	<brief_summary>The purpose study ass abuse potential CL-108 tablet , include abuse deterrent effect promethazine , follow oral administration , relative hydrocodone/acetaminophen ( APAP ) tablets placebo non-dependent , recreational opioid user .</brief_summary>
	<brief_title>A Study Opioid-Experienced , Non-Dependent Recreational Drug Users Determine Abuse Potential Safety CL-108 Tablets Administered Via Oral Route</brief_title>
	<detailed_description>The purpose study ass abuse potential CL-108 tablet , include abuse deterrent effect promethazine , follow oral administration , relative hydrocodone/acetaminophen ( APAP ) tablets placebo non-dependent , recreational opioid user ; assess cognitive behavioral effect CL-108 tablet follow oral administration relative hydrocodone/APAP tablet placebo non-dependent , recreational opioid user ; assess safety orally administer CL-108 tablet relative hydrocodone/APAP tablet placebo non-dependent , recreational opioid user .</detailed_description>
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Hydrocodone</mesh_term>
	<mesh_term>Diphenhydramine</mesh_term>
	<mesh_term>Promethazine</mesh_term>
	<criteria>BMI within 18.0 33.0 kg/m2 , inclusive ( minimum weight 50.0 kg Screening ) Healthy , determine clinically significant medical history , physical examination finding , 12lead ECG finding , vital sign measurement , laboratory result screen , judge investigator Current opioid user use oral opioids recreational ( nontherapeutic ) purpose , least 10 time past year Drug alcohol dependence within last 12 month ( except nicotine ) Subjects ever treatment substance use disorder ( except smoke cessation History presence clinically significant cardiac , neurologic , pulmonary , psychiatric , endocrine , hematologic , hepatic , immunologic , metabolic , urologic , dermatologic , renal , major disease screening , opinion investigator , would jeopardize safety subject validity study result History presence hypotension , judge clinically significant base investigator judgement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Pain</keyword>
	<keyword>Nausea</keyword>
	<keyword>Vomiting</keyword>
</DOC>